Senior insider sale
Chief Medical Officer at DEFINIUM THERAPEUTICS, INC. — senior position signals high conviction
$128.7K
15.55K shares
What this filing means
KARLIN DANIEL plans to sell 15.55K shares of DEFINIUM THERAPEUTICS, INC. valued at approximately $128.7K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/25/2025ACC: 0001950047-25-007517
Officer· Chief Medical Officer
Since Jan 2022
15.55K
Shares to sell
$128.7K
Approx. market value
7.70K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted stock vesting under a registered plan
Not Applicable
9/25/2025
7.70KTotal acquired7.70K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/25/2025 | Restricted stock vesting under a registered plan Not Applicable | 7.70K | — |
| Total | 7.70K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
7.85K
Market value
$53.4K
6/25/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
7.70K
Market value
$75.3K
9/25/2025
Total
Units
15.55K
Value
$128.7K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
6/25/2025 | 7.85K | $53.4K | — | Completed |
| Planned — Approximate Date | ||||
9/25/2025 | 7.70K | $75.3K | NASDAQ | Planned |
| Total | 15.55K | $128.7K | ||